original case study here: https://iuk-business-connect.org.uk/casestudy/innovate-uk-helps-calla-lily-bloom-in-womens-health/ Calla Lily Clinical Care is reshaping how vaginally administered drugs are delivered, starting with miscarriage prevention and fertility. With tailored business growth support from Innovate UK Business Growth, the London-based medical device company has secured £2.2 million in grant funding and more than £4.5 million in private investment, and …
Welcome to Florence Thatcher who joins as our Project Manager. Florence is a seasoned leader in medical device development and new product introductions, with a decade of experience spanning engineering, product development, and human centere deesign. 🔥 At bioMérieux, she spent nine years building technologies and leading complex programs focused on point-of-care diagnostics for infectious …
Yesterday, Calla Lily Clinical Care hosted our Summer Shareholder Reception at our London HQ — and simply put, it was wonderful. We were so pleased to welcome 36 of our shareholders, including several who traveled from as far as Barcelona 🇪🇸 and the U.S. 🇺🇸 , to visit our facilities and meet our fast-growing team. …
Delighted to welcome Lucia Huo to the Calla Lily Clinical Care team this summer! Lucia is a graduate student in the Technology and Policy Program at the Massachusetts Institute of Technology MIT Institute for Data, Systems, and Society (IDSS), where she researches machine learning applications in healthcare and public health. Prior to MIT, she spent …
Welcome Harley Carroll as our Research & Product Development Intern! 🔬 Harley is a rising senior studying biological engineering at Massachusetts Institute of Technology. With hands-on experience in cell biology / microbiology and a strong interest in hashtag medical device design (including experience developing implantable dual-function biosensor & progesterone delivery devices!), she will be working …
We have arrived in Amsterdam for HLTH Europe — the continent’s leading health innovation event! 🇳🇱✨ We’re proud to be named a finalist for one of the Most Innovative Startups of the year. 💥 Come visit us at Booth *D140-16* to see how we are modernising drug delivery for women — with science-backed solutions and …
The first day of the LSI Asia’s Emerging Medtech conference in Singapore has been superb – and particularly pleased with the response from my presentation on our Callavid® vaginal drug delivery platform. Driven by growing regional concerns over declining fertility and birth rates across Asia, our initial focus on supporting IVF and miscarriage prevention has …
Great networking evening at Calla Lily Clinical Care last night. Such a diverse group of people interested in women’s health spent the evening NOT MOANING but brainstorming on ways we can work together to change the world. The power of the network to find solutions through collective action. Thank you to my awesome team for …
We’re delighted to welcome Scheilly Tsilova, Ph.D to the Calla Lily Clinical Care team as our new Senior Pharmaceutical Scientist. 🥼 For the past two years, Scheilly has been instrumental in advancing our Callavid® vaginal drug delivery technology while pursuing her PhD at UCL, with a focus on polymer-based drug delivery systems. Her deep technical …
Spending time in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting was even better than I had hoped. Besides the constant engagement with passionate American OBGYNs (so many of which are excited to hear about our Callavid® drug delivery technology) – it was superb to connect with other …